<code id='95C2043D28'></code><style id='95C2043D28'></style>
    • <acronym id='95C2043D28'></acronym>
      <center id='95C2043D28'><center id='95C2043D28'><tfoot id='95C2043D28'></tfoot></center><abbr id='95C2043D28'><dir id='95C2043D28'><tfoot id='95C2043D28'></tfoot><noframes id='95C2043D28'>

    • <optgroup id='95C2043D28'><strike id='95C2043D28'><sup id='95C2043D28'></sup></strike><code id='95C2043D28'></code></optgroup>
        1. <b id='95C2043D28'><label id='95C2043D28'><select id='95C2043D28'><dt id='95C2043D28'><span id='95C2043D28'></span></dt></select></label></b><u id='95C2043D28'></u>
          <i id='95C2043D28'><strike id='95C2043D28'><tt id='95C2043D28'><pre id='95C2043D28'></pre></tt></strike></i>

          Home / knowledge / explore

          explore


          explore

          author:fashion    Page View:91552
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In